medical guideline
首页
中医/中西医结合指南
肿瘤学指南
泌尿外科指南
关于我们
郑重声明
联系我们
首页
肿瘤学指南
检索结果
人体系统
运动
骨肿瘤
软组织肿瘤
骨与软组织肿瘤
硬纤维瘤
骶尾部畸胎瘤
神经
中枢神经系统肿瘤
嗜铬细胞瘤和副神经节瘤
副神经节瘤
胶质细胞瘤
前庭神经鞘瘤
星形胶质细胞瘤和少突胶质细胞瘤
弥漫性胶质瘤
神经纤维瘤
神经细胞瘤
神经内分泌肿瘤
内分泌
甲状腺肿瘤
垂体肿瘤
肾上腺肿瘤
甲状旁腺肿瘤
胸腺肿瘤
神经内分泌肿瘤
循环
心脏肿瘤
淋巴瘤
骨髓瘤
白血病
血液肿瘤
血管瘤
呼吸
肺癌
鼻咽癌
喉部肿瘤
下咽癌
鼻腔和副鼻窦癌
呼吸道肿瘤
鼻颅咽管瘤
淋巴管肌瘤
消化
胰腺肿瘤
口腔癌
肛门癌
口咽癌
胆囊癌
胆管肿瘤
直肠癌
结肠癌
胃癌
小肠癌
肝癌
大肠肿瘤
唾液腺癌
阑尾肿瘤
食管肿瘤
肝肿瘤
壶腹肿瘤
肝胆癌
结直肠肿瘤
食管胃肿瘤
胃肠道肿瘤
消化道肿瘤
泌尿
膀胱肿瘤
肾癌
脐尿管癌
尿路上皮癌
肾血管平滑肌脂肪瘤
泌尿生殖肿瘤
生殖
女性
子宫肿瘤
卵巢肿瘤
乳腺肿瘤
阴道肿瘤
输卵管癌
外阴癌
妊娠滋养细胞肿瘤
妇科肿瘤
男性
前列腺肿瘤
性索间质瘤
睾丸肿瘤
阴茎癌
男性乳腺肿瘤
泌尿生殖肿瘤
其他
症状管理
治疗方案
诊断/检测/评估方法
预防和筛查
COVID-19大流行癌症患者相关指导建议
皮肤肿瘤
黑色素瘤
头颈部肿瘤
康复营养
生育能力
体力活动
心理健康
腹膜肿瘤
实体瘤
胸部肿瘤
长期监测
Cowden综合征
转诊
遗传性癌症综合征
癌症患者其他类问题管理
寡转移性疾病
基因测序
易感基因变异的分类
外科肿瘤
罕见癌症
不明原因癌症
纤维瘤
腹部肿瘤
老年肿瘤
儿童/青少年肿瘤
人类微生物组与癌变
检索结果
按关键字
按标题
按关键词
按摘要
按作者
按期刊
按发表年份
共搜索到
11条
与
Recurrent
有关的结果
The 2020 Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
2021年 发布于
Journal of Gynecologic Oncology
32卷 第2期
所属人体系统：
其他
|
腹膜肿瘤
Japan Society of Gynecologic Oncology
The Fifth Edition of the Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer Was Published in 2020. the Guidelines Contain 6 Chapters-namely
(1) Overview of the Guidelines
(2) Epithelial Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer
(3)
Recurrent
Epithelial Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer
(4) Borderline Epithelial Tumors of the Ovary
(5) Malignant Germ Cell Tumors of the Ovary
and (6) Malignant Sex Cord-stromal Tumors. Furthermore
the Guidelines Comprise 5 Algorithms-namely
(1) Initial Treatment for Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer
(2) Treatment for
Recurrent
Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer
(3) Initial Treatment for Borderline Epithelial Ovarian Tumor
(4) Treatment for Malignant Germ Cell Tumor
and (5) Treatment for Sex Cord-stromal Tumor. Major Changes in the New Edition Include the Following: (1) Revision of the Title to "guidelines for the Treatment of Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer"
(2) Involvement of Patients and General (male/female) Participants in Addition to Physicians
Pharmacists
and Nurses
(3) Clinical Questions (CQs) in the PICO Format
(4) Change in the Expression of Grades of Recommendation and Level of Evidence in Accordance with the GRADE System
(5) Introduction of the Idea of a Body of Evidence
(6) Categorization of References According to Research Design
(7) Performance of Systematic Reviews and Meta-analysis for Three CQs
and (8) Voting for Each CQ/recommendation and Description of the Consensus.
指南简介
原文链接
The 2020 Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
2021年 发布于
Journal of Gynecologic Oncology
32卷 第2期
所属人体系统：
生殖
|
输卵管癌
Japan Society of Gynecologic Oncology
The Fifth Edition of the Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer Was Published in 2020. the Guidelines Contain 6 Chapters-namely
(1) Overview of the Guidelines
(2) Epithelial Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer
(3)
Recurrent
Epithelial Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer
(4) Borderline Epithelial Tumors of the Ovary
(5) Malignant Germ Cell Tumors of the Ovary
and (6) Malignant Sex Cord-stromal Tumors. Furthermore
the Guidelines Comprise 5 Algorithms-namely
(1) Initial Treatment for Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer
(2) Treatment for
Recurrent
Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer
(3) Initial Treatment for Borderline Epithelial Ovarian Tumor
(4) Treatment for Malignant Germ Cell Tumor
and (5) Treatment for Sex Cord-stromal Tumor. Major Changes in the New Edition Include the Following: (1) Revision of the Title to "guidelines for the Treatment of Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer"
(2) Involvement of Patients and General (male/female) Participants in Addition to Physicians
Pharmacists
and Nurses
(3) Clinical Questions (CQs) in the PICO Format
(4) Change in the Expression of Grades of Recommendation and Level of Evidence in Accordance with the GRADE System
(5) Introduction of the Idea of a Body of Evidence
(6) Categorization of References According to Research Design
(7) Performance of Systematic Reviews and Meta-analysis for Three CQs
and (8) Voting for Each CQ/recommendation and Description of the Consensus.
指南简介
原文链接
The 2020 Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
2021年 发布于
Journal of Gynecologic Oncology
32卷 第2期
所属人体系统：
生殖
|
卵巢肿瘤
Japan Society of Gynecologic Oncology
The Fifth Edition of the Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer Was Published in 2020. the Guidelines Contain 6 Chapters-namely
(1) Overview of the Guidelines
(2) Epithelial Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer
(3)
Recurrent
Epithelial Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer
(4) Borderline Epithelial Tumors of the Ovary
(5) Malignant Germ Cell Tumors of the Ovary
and (6) Malignant Sex Cord-stromal Tumors. Furthermore
the Guidelines Comprise 5 Algorithms-namely
(1) Initial Treatment for Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer
(2) Treatment for
Recurrent
Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer
(3) Initial Treatment for Borderline Epithelial Ovarian Tumor
(4) Treatment for Malignant Germ Cell Tumor
and (5) Treatment for Sex Cord-stromal Tumor. Major Changes in the New Edition Include the Following: (1) Revision of the Title to "guidelines for the Treatment of Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer"
(2) Involvement of Patients and General (male/female) Participants in Addition to Physicians
Pharmacists
and Nurses
(3) Clinical Questions (CQs) in the PICO Format
(4) Change in the Expression of Grades of Recommendation and Level of Evidence in Accordance with the GRADE System
(5) Introduction of the Idea of a Body of Evidence
(6) Categorization of References According to Research Design
(7) Performance of Systematic Reviews and Meta-analysis for Three CQs
and (8) Voting for Each CQ/recommendation and Description of the Consensus.
指南简介
原文链接
Initial Management of Noncastrate Advanced, Recurrent, Or Metastatic Prostate Cancer: ASCO Guideline Update
2021年 发布于
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
39卷 第11期
所属人体系统：
生殖
|
前列腺肿瘤
American Society of Clinical Oncology
Noncastrate Advanced
Recurrent
Metastatic Prostate Cancer
Management
Guideline
指南简介
原文链接
2020 Imaging Guidelines for Thyroid Nodules and Differentiated Thyroid Cancer: Korean Society of Thyroid Radiology
2021年 发布于
Korean journal of radiology
22卷 第5期
所属人体系统：
内分泌
|
甲状腺肿瘤
Korean Society of Thyroid Radiology
Guideline
Thyroid
Thyroid Malignancy
Thyroid Nodule
Thyroid
Recurrent
Cancers.
指南简介
原文链接
Initial Management of Non-Castrate Advanced, Recurrent Or Metastatic Prostate Cancer
2021年 发布于
American Society of Clinical Oncology
卷 第期
所属人体系统：
生殖
|
前列腺肿瘤
American Society of Clinical Oncology
Prostate Cancer
Metastatic
Recurrent
Advanced
Initial Management
Non-Castrate
指南简介
原文链接
Transurethral Laser Ablation for Recurrent Non-muscle-invasive Bladder Cancer
2019年 发布于
National Institute for Health and Care Excellence
卷 第期
所属人体系统：
泌尿
|
膀胱肿瘤
National Institute for Health and Care Excellence
NMIBC
recurrent
transurethral Laser Ablation
指南简介
原文链接
ESMO-ESGO Consensus Conference Recommendations on Ovarian Cancer: Pathology and Molecular Biology, Early and Advanced Stages, Borderline Tumours and Recurrent Disease
2019年 发布于
Int J Gynecol Cancer
29卷 第_期
所属人体系统：
生殖
|
卵巢肿瘤
European Society for Medical Oncology
European Society of Gynaecologic Oncology Ovarian Cancer Consensus Conference Working Group
Adjuvant Treatment
Molecular Biology
Ovarian Cancer
Pathology
Recurrent
Disease
Surgery
指南简介
原文链接
2017 Thyroid Radiofrequency Ablation Guideline: Korean Society of Thyroid Radiology
2018年 发布于
Korean J Radiol
19卷 第4期
所属人体系统：
内分泌
|
甲状腺肿瘤
韩国甲状腺放射学会 (KSThR)
Guideline
RF Ablation
Radiofrequency Ablation
Thyroid
Thyroid
Recurrent
Cancers
Ultrasound
指南简介
原文链接
Surgical Management of the Recurrent Laryngeal Nerve in Thyroidectomy: American Head and Neck Society Consensus Statement
2018年 发布于
Head Neck
40卷 第4期
所属人体系统：
内分泌
|
甲状腺肿瘤
American Head and Neck Society
Ligament of Berry
Laryngeal
Nerve
Recurrent
Thyroidectomy
指南简介
原文链接
International Neuromonitoring Study Group Guidelines 2018: Part II: Optimal Recurrent Laryngeal Nerve Management for Invasive Thyroid Cancer—incorporation of Surgical, Laryngeal, and Neural Electrophysiologic Data
2018年 发布于
Laryngoscope
128卷 第Suppl 3期
所属人体系统：
内分泌
|
甲状腺肿瘤
International Neuromonitoring Study Group
Thyroid Malignancy
Bilateral Surgery
Intraoperative Neuromonitoring
Invaded Nerve
Nerve Preservation
Nerve Resection
Only Functional Nerve
Recurrent
Laryngeal Nerve
Thyroid Surgery
Vocal Cord Paralysis
指南简介
原文链接
